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ABSTRACT 
A practical and convenient synthesis of naturally occurring farinomaleins C-E was achieved 
starting from readily available ethyl 3-methyl-2-oxobutyrate and triethyl phosphonoacetate. The 
key steps of the sequence included a Horner-Wadsworth-Emmons condensation to obtain the 
precursor farinomalein A and coupling with suitable alcohols to install the chain. The synthesis 
of farinomalein D has been achieved starting from (R)-isopropylideneglycerol on the basis of 
which the S configuration was assigned to the natural compound. The antifungal activity of the 
synthesized compounds was evaluated against Cladosporium cladosporioides. 
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As part of our studies on the synthesis of natural compounds endowed with antifungal activity, 
we have recently focused our attention on farinomalein A, a simple maleimide isolated in 2009 
from the entomopathogenic fungus Paecilomyces farinosus by Putri et.al.1 The compound 
showed potent inhibition of Phytophtora sojae, a plant pathogen that every year causes enormous 
damage to soybean crops. Recently, El Amrani et al.2 have isolated three new farinomalein 
derivatives, farinomaleins C-E, from an unidentified endophytic fungus of the mangrove plant 
Avicennia marina from Oman. We describe herein a short and convenient synthesis of these new 
compounds, which are naturally occurring esters of farinomalein A (Figure 1).  
 
* Corresponding author Tel. +39 2 50316818 Fax +39 2 50316801 E-mail address: 
sabrina.dallavalle@unimi.it 
 
 
NO
O
O
O
OH
OH
N
O
O
OR
O
Farinomalein A (1)  R = H
Farinomalein C (2) R = C4H9
Farinomalein D (3)
Farinomalein E (4)
N O OH
O
O
O O
 
Figure 1. Structures of farinomaleins. 
The first synthetic approach to farinomalein A was reported by Miles and Yan.3 The sequence is 
based on the reaction of isovaleraldehyde and glyoxylic acid to give a γ-hydroxybutenolide. 
Successive oxidation to the corresponding anhydride and treatment with β-alanine affords 
farinomalein A. However, the Authors themselves state that their synthesis is difficult to scale-
up,3 due to the use of the hazardous and expensive oxidant Dess-Martin periodinane. More 
recently, an alternative strategy for the preparation of farinomalein A has been reported by us.4 
The synthesis has been developed in four steps with high yield and without using any hazardous 
chemical (Scheme 1).  
We envisioned that farinomaleins C-E could be synthesized by simply coupling farinomalein A, 
obtained from the previously reported procedure, with suitable alcohols. Thus, farinomalein C 
was obtained in 92% yield by reacting farinomalein A with 1-butanol using DCC and DMAP in 
DCM (Scheme 1)5.  
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Scheme 1. Synthesis of farinomaleins A, C and D. 
Similarly, the synthesis of farinomalein D was carried out. As the absolute configuration at C-2’ 
was not assigned by the Authors, we decided to synthesize both the enantiomers along with 
racemic farinomalein D. Scheme 1 summarizes the synthesis of (R)-farinomalein D ((R)-3) from 
(S)-9. After coupling with farinomalein A using DCC and DMAP,6 deprotection of 10 was first 
attempted by using SmCl2 in ethanol at reflux. This method allowed to obtain the desired 
compound in high yield but with complete racemization. Therefore, removal of the protecting 
group was carried out in AcOH/H2O (4:1, v/v) maintaining the temperature at 50 °C for 3h, as 
reported by Mori.7 (R)-Farinomalein D,8 obtained in 70% yield, showed optical rotation opposite 
to that reported for the natural compound ([α]D25 -7.2 (c 1.0, MeOH ), lit.4: [α]D25 +7.9 (c 
0.03,MeOH)). 
The same reaction pathway was followed to prepare (S)-farinomalein D (S)-3 starting from (R)-9 
in 58% overall yield ([α]D25 +7.3 (c 1.0, MeOH)). Racemic farinomalein D was also prepared for 
structure-activity relationship studies, starting from DL-1,2-isopropylideneglycerol.  
As (S)-farinomalein D showed the same sign of specific rotation reported for the natural 
compound, we may safely deduce that the absolute configuration of natural farinomalein D is S. 
 
 After several attempts, an optimized reaction sequence for the synthesis of farinomalein E was 
developed (Scheme 2). The carbonyl group of β-keto ester 11 was protected using standard 
methodology providing ketal 12.9 Reduction of 12 with lithium aluminium hydride gave the 
primary alcohol 13 in 91% yield. In the key transformation, treatment of β-hydroxy ketal 13 with 
oxalic acid and wet silica gel according to the procedure by Hitchcock10 provided the β-
hydroxyketone 14 in high yield without elimination products. Compound 14 was protected as 
tetrahydropyranyl derivative (15)11 and this latter was condensed with methyl 
(triphenylphosphoranylidene) acetate via benzoic acid catalyzed Wittig reaction.12 A 3:2 mixture 
of Z and E α,β-unsaturated esters 16 and 17 was produced. The mixture was treated with 
methanolic HCl without separation of the stereoisomers. Following removal of the THP group, 
the Z isomer 16 underwent spontaneous lactonization to 18 and could thus be removed in a facile 
chromatographic separation from the desired hydroxyester 19 (43% yield after purification). 
Finally, saponification with sodium hydroxide in water, followed by acidification, gave the acid 
20 in quantitative yield. Farinomalein E was then obtained by coupling of 20 with farinomalein 
A in 42% yield.13 
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Scheme 2. Synthesis of farinomalein E.   
 The antifungal activity of the synthesized natural compounds (farinomaleins A, C-E) was 
investigated on Cladosporium cladosporioides using the method of bioautography.14,15 
The results confirmed that farinomalein A is endowed with antifungal activity on this pathogen, 
the minimum amount required for the inhibition of fungal growth on thin-layer chromatography 
(TLC) plates being 5 µg. Interestingly, farinomalein C showed a ten-fold increased potency, 
inhibiting the fungal growth at 0.5 µg. Farinomalein E and (R)-/ (S)- / racemic farinomaleins D 
all showed a lower activity (20 µg), thus confirming that the stereochemistry did not affect the 
antifungal activity (Table 1).    
To depict preliminary structure-activity relationships for this class of compounds, the results 
were compared to those obtained testing a series of farinomalein A derivatives previously 
prepared by our group4 (compounds 21a-d, Figure 2). 
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Figure 2. Structures of farinomalein A analogues. 
 
The minimum amount of compounds 21a–d required for fungal growth inhibition was 6 to 10-
fold larger than for 1 (30–50 µg) (Table 1). 
The results clearly indicate that the introduction of different chains α to the carboxylic group, or 
the esterification with polar moieties, was detrimental for activity. Conversely, a lipophilic chain 
as in farinomalein C led to an increase of activity, comparable with that of the reference 
compound prochloraz. These data confirm that farinomaleins can be considered promising 
candidates in the field of antifungal compounds.  
Current efforts are directed towards the synthesis of new analogues. Notwithstanding the fact 
that the molecular mechanism of action of the reported compounds remains to be defined, 
structure-activity information inferred from our study could provide a basis for rational design of 
new structurally simple antifungal agents and the starting point for their optimization. 
Table 1. Antifungal activity of farinomaleins. 
Compound Antifungal activity (μg)a  
C. cladosporioides 
1 5 
2 0.5 
3 20 
4 20 
21a 50 
21b 50 
21c 30 
21d 50 
prochloraz 0.1 
a
 Minimum amount required for the inhibition of fungal 
growth on thin-layer chromatography plates (TLC). 
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